| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/20/2011 | CN102125688A Medicinal composition for treating gastric ulcer |
| 07/20/2011 | CN101244036B High dispersion does type containing cholesterol group phosphoryl nucleoside analogue |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7981899 Skin aging resistance, wrinkling resistance; (S)-1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981861 Method of performing angioplasty with a GLP-1 molecule |
| 07/19/2011 | US7981598 Preventive/remedy for respiratory diseases |
| 07/19/2011 | US7981421 Combinations of antibodies selective for DR5 and other therapeutic agents |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2494015C Antibiotic product, use and formulation thereof |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2475818C Aryl ureas as kinase inhibitors |
| 07/19/2011 | CA2473218C Disease susceptibility gene for rheumatoid arthritis, protein thereof, evaluation method and evaluation kit for evaluating onset possibility of rheumatoid arthritis by using those, and remedy and curing medicine for rheumatoid arthritis |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2011 | CA2380920C Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 07/19/2011 | CA2341441C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 07/19/2011 | CA2321900C Agents with serotonin-related activity for the treatment for sleep apnea |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
| 07/14/2011 | WO2011085216A2 Use of faah inhibitors for treating parkinson's disease and restless legs syndrome |
| 07/14/2011 | WO2011085198A1 Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph) |
| 07/14/2011 | WO2011084968A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer |
| 07/14/2011 | WO2011084610A1 Liposomes for preventing the spread of hiv |
| 07/14/2011 | WO2011084108A1 Methods and compositions for treating cancer |
| 07/14/2011 | WO2011083830A1 Novel anticancer agent and method for screening same |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083469A1 Treatment with vb-201 |
| 07/14/2011 | WO2011083467A1 Combined treatment utilizing vb-201 |
| 07/14/2011 | WO2011083291A1 Combinations comprising an ant i -inflammatory agent and/or an antibacterial agent and a glycosylamine and their use in medicine |
| 07/14/2011 | WO2011082951A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 07/14/2011 | WO2011082950A1 Combination preparations comprising exosomes and corticosteroid |
| 07/14/2011 | WO2011038924A9 Proteasome inhibitors for treating cancer |
| 07/14/2011 | WO2010049709A8 Therapeutic compositions comprising phenolic acids for treating conditions related to inappropriate platelet aggregation |
| 07/14/2011 | US20110172253 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172213 Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| 07/14/2011 | US20110172178 Beta-l-2' deoxynucleosides for the treatment of resistant hbv strains and combination therapies |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172149 Method of Regulating Glucose Metabolism, and Reagents Related Thereto |
| 07/14/2011 | US20110171289 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 07/14/2011 | US20110171271 Citrate-Based Dialysate Chemical Formulations |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | CA2786777A1 Obesity small molecules |
| 07/14/2011 | CA2786266A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer |
| 07/14/2011 | CA2781576A1 Combination preparation including a corticosteroid and exosomes |
| 07/14/2011 | CA2781223A1 Combination preparation including a cytokine antagonist and corticosteroid |
| 07/13/2011 | EP2343088A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 07/13/2011 | EP2343078A1 Light-stabilized pharmaceutical composition |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343073A2 Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343067A1 Pharmaceutical composition for the eradication of helicobacter pylori and preparation method thereof |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2343047A2 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 07/13/2011 | EP2342188A1 Chromenone analogs as sirtuin modulators |
| 07/13/2011 | EP2341938A2 Use of an ang-(1-7) receptor agonist in acute lung injury |
| 07/13/2011 | EP2341911A2 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors |
| 07/13/2011 | EP2341904A1 Methods for treatment of multiple sclerosis |
| 07/13/2011 | EP2341903A1 Cannabinoids for use in treating or preventing cognitive impairment and dementia |
| 07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 07/13/2011 | EP1860185B1 Screening method |
| 07/13/2011 | EP1737467B1 Composition for the treatment of skin conditions |
| 07/13/2011 | EP1733723B1 Medicine capable of inhibiting activation of transcription factor klf5 |
| 07/13/2011 | EP1667655B1 New use, pharmaceutical preparations as well as a process for their production |
| 07/13/2011 | EP1545553B1 Use of alkyl phosphocholines in combination with antitumor medicaments |
| 07/13/2011 | EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/13/2011 | EP1395128B2 Acid controlled viscosity fibre system and uses thereof |
| 07/13/2011 | EP1181001B1 Sunscreen composition containing sol-gel microcapsules |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1960759B Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/13/2011 | CN102123736A Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123712A Methods of cancer treatment with IGF1R inhibitors |
| 07/13/2011 | CN102123703A 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102120037A Human epididymis secretion sperm bonding protein HEL-S-64C as well as coding gene and application thereof |
| 07/13/2011 | CN102120031A Pharmaceutical compositions and methods for accelerating wound healing |
| 07/13/2011 | CN102120030A Medicament of ilaprazole chemical structure and application thereof |
| 07/13/2011 | CN102119923A Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977307 Method for reducing pain with ziconotide and morphine |
| 07/12/2011 | US7976876 Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use |
| 07/12/2011 | US7976835 Methods and compositions for preventing and treating solid tumors |
| 07/12/2011 | CA2524394C Novel benzodiazepine compounds, compositions and uses thereof |
| 07/12/2011 | CA2511619C Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 07/12/2011 | CA2495541C Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2480266C Use of an alpha2-adrenoreceptor antagonist for cns-related diseases |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2445341C Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof |
| 07/12/2011 | CA2421575C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |